SVP Clinical Development Jeffrey Wiezorek sold $404K of Kite Pharma, Inc.

Sold$403,943

$44.88Price

9,000Shares

−38%Stake

What KITE did after the filing

Prices for KITE after this filing aren't in yet.

Traded Tue, Mar 15. Filed Thu, Mar 17, 5:15 PM ET, after the close. Not investment advice.